These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24412498)

  • 1. Synthesis and assay of retro-α4β1 integrin-targeting motifs.
    Dattoli SD; De Marco R; Baiula M; Spampinato S; Greco A; Tolomelli A; Gentilucci L
    Eur J Med Chem; 2014 Feb; 73():225-32. PubMed ID: 24412498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New 4-Aminoproline-Based Small Molecule Cyclopeptidomimetics as Potential Modulators of α
    Sartori A; Bugatti K; Portioli E; Baiula M; Casamassima I; Bruno A; Bianchini F; Curti C; Zanardi F; Battistini L
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses.
    Lin Kc; Ateeq HS; Hsiung SH; Chong LT; Zimmerman CN; Castro A; Lee WC; Hammond CE; Kalkunte S; Chen LL; Pepinsky RB; Leone DR; Sprague AG; Abraham WM; Gill A; Lobb RR; Adams SP
    J Med Chem; 1999 Mar; 42(5):920-34. PubMed ID: 10072689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-aminomethyloxazolidine-2,4-dione hybrid α/β-dipeptide scaffolds as inductors of constrained conformations: Applications to the synthesis of integrin antagonists.
    De Marco R; Mazzotti G; Dattoli SD; Baiula M; Spampinato S; Greco A; Gentilucci L
    Biopolymers; 2015 Sep; 104(5):636-49. PubMed ID: 26211418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Pharmacological Characterization, and Molecular Docking of Minimalist Peptidomimetic Antagonists of α
    Baiula M; Anselmi M; Musiani F; Ghidini A; Carbone J; Caligiana A; Maurizio A; Spampinato S; Gentilucci L
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4.
    Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB
    Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent in vivo suppression of inflammation by selectively targeting the high affinity conformation of integrin α4β1.
    Vanderslice P; Woodside DG; Caivano AR; Decker ER; Munsch CL; Sherwood SJ; Lejeune WS; Miyamoto YJ; McIntyre BW; Tilton RG; Dixon RA
    Biochem Biophys Res Commun; 2010 Oct; 400(4):619-24. PubMed ID: 20807504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of ligand-induced and ligand-attenuated epitopes on the leukocyte integrin alpha4beta1: VCAM-1, mucosal addressin cell adhesion molecule-1, and fibronectin induce distinct conformational changes.
    Newham P; Craig SE; Clark K; Mould AP; Humphries MJ
    J Immunol; 1998 May; 160(9):4508-17. PubMed ID: 9574557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small molecule alpha4beta1/alpha4beta7 antagonist differentiates between the low-affinity states of alpha4beta1 and alpha4beta7: characterization of divalent cation dependence.
    Egger LA; Cao J; McCallum C; Kidambi U; Van Riper G; McCauley E; Mumford RA; Lanza TJ; Lin LS; de Laszlo SE; Young DN; Yang G; Dean DC; Raab CE; Wallace MA; Jones AN; Hagmann WK; Schmidt JA; Pepinsky RB; Scott DM; Lee WC; Cornebise MA; Detmers PA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):903-13. PubMed ID: 12766251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic RGD and
    Panzeri S; Arosio D; Gazzola S; Belvisi L; Civera M; Potenza D; Vasile F; Kemker I; Ertl T; Sewald N; Reiser O; Piarulli U
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and analysis of a polyethelene glycol-modified (PEGylated) small molecule inhibitor of integrin {alpha}4{beta}1 with improved pharmaceutical properties.
    Pepinsky RB; Lee WC; Cornebise M; Gill A; Wortham K; Chen LL; Leone DR; Giza K; Dolinski BM; Perper S; Nickerson-Nutter C; Lepage D; Chakraborty A; Whalley ET; Petter RC; Adams SP; Lobb RR; Scott DM
    J Pharmacol Exp Ther; 2005 Feb; 312(2):742-50. PubMed ID: 15485895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular toolkit for the functionalization of titanium-based biomaterials that selectively control integrin-mediated cell adhesion.
    Rechenmacher F; Neubauer S; Mas-Moruno C; Dorfner PM; Polleux J; Guasch J; Conings B; Boyen HG; Bochen A; Sobahi TR; Burgkart R; Spatz JP; Fässler R; Kessler H
    Chemistry; 2013 Jul; 19(28):9218-23. PubMed ID: 23744802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of αvβ₃- and α₅β₁-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics.
    Tolomelli A; Baiula M; Belvisi L; Viola A; Gentilucci L; Troisi S; Dattoli SD; Spampinato S; Civera M; Juaristi E; Escudero M
    Eur J Med Chem; 2013 Aug; 66():258-68. PubMed ID: 23811088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DS-70, a novel and potent α
    Dattoli SD; Baiula M; De Marco R; Bedini A; Anselmi M; Gentilucci L; Spampinato S
    Br J Pharmacol; 2018 Oct; 175(20):3891-3910. PubMed ID: 30051467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDV peptidomimetics equipped with biotinylated spacer-arms: synthesis and biological evaluation on CCRF-CEM cell line.
    Gérard E; Meulle A; Feron O; Marchand-Brynaert J
    Bioorg Med Chem Lett; 2012 Jan; 22(1):586-90. PubMed ID: 22101134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
    Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
    Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of tyrosine modified analogues of the α4β7 integrin inhibitor biotin-R₈ERY.
    Papst S; Noisier AF; Brimble MA; Yang Y; Krissansen GW
    Bioorg Med Chem; 2012 Sep; 20(17):5139-49. PubMed ID: 22877871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
    Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
    Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
    Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
    J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic RGD peptidomimetics containing 4- and 5-amino-cyclopropane pipecolic acid (CPA) templates as dual αVβ3 and α5β1 integrin ligands.
    Sernissi L; Trabocchi A; Scarpi D; Bianchini F; Occhiato EG
    Bioorg Med Chem; 2016 Feb; 24(4):703-11. PubMed ID: 26753814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.